Advisory Services Network’s Kyntra Bio KYNB Stock Holding History

Advisory Services Network’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-80	Closed	-$53K	–	2031
2021 Q2	$53K	Buy	+80	New	+$46.1K	﹤0.01%	1966
2021 Q1	–	Hold	0	–	–	–	1854
2020 Q4	–	Sell	-5	Closed	-$5.26K	–	3416
2020 Q3	$5K	Buy	+5	New	+$5.38K	﹤0.01%	2763
2020 Q2	–	Hold	0	–	–	–	1602
2020 Q1	–	Hold	0	–	–	–	3115
2019 Q4	–	Hold	0	–	–	–	3132

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Services Network's KYNB Position: Q3 2021 in Review

Advisory Services Network sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 80 shares — an estimated $53K sold.

Advisory Services Network first reported a position in KYNB in Q3 2020 and held it in 2 quarters. The position peaked at $53K in Q2 2021. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

Advisory Services Network reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
Advisory Services Network sold 80 Kyntra Bio shares in Q3 2021, an estimated $53K.
Advisory Services Network first reported a position in Kyntra Bio in Q3 2020 and held it in 2 quarters.
Advisory Services Network's Kyntra Bio position peaked at $53K in Q2 2021.
164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.